JEFFREY J. KIMBELL & ASSOCIATES, INC.

Lobbying for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY · Issues related to pharmaceutical drugs

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $20,000.00 income · posted Apr 16, 2025

Lobbying activity 1

Health Issues

Issue related to pharmaceutical compounding; Issues related to Domestic manufacturing; Issues related to 340B; Implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill; Issues related to supply chain resilience

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.